Measuring Sleep Problems in Children with Autism Spectrum Disorder
测量自闭症谱系障碍儿童的睡眠问题
基本信息
- 批准号:9803060
- 负责人:
- 金额:$ 66.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-13 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgeAgreementAnxietyArousalBedsBehaviorBehavior TherapyBehavioralChildChildhoodClassificationClinicClinical DataClinical assessmentsCodeCognitiveCommunity SurveysDataData ReportingDevelopmentDevelopmental DisabilitiesEnsureFactor AnalysisFamilyFocus GroupsFutureHabitsHealthHyperactive behaviorImpairmentInformation SystemsIntervention StudiesLanguageLanguage DelaysLearningLinear RegressionsMeasurementMeasuresMedicalMethodsModelingMonitorMonographOhioOutcomeOutcome MeasureParentsPatient Outcomes AssessmentsPersonsPharmaceutical PreparationsPharmacological TreatmentPolysomnographyPopulationPrimary InsomniaQuestionnairesReadingReceiver Operating CharacteristicsReportingResearch DesignResearch PersonnelSamplingSecondary InsomniaSecureSensitivity and SpecificitySiteSleepSleep DeprivationSleep DisordersSleep disturbancesSleeplessnessStructureSurveysTestingTimeValidity and ReliabilityWithdrawalYouthactigraphyadverse outcomeage groupautism spectrum disorderautistic childrenbasebehavior testclinical practicedesignemotion regulationfallsimmune functionindexinginformantpatient populationrecruitrepetitive behaviorresponsescreeningside effectsocialtheoriesweb site
项目摘要
Project Summary / Abstract.
This application, written in response to PAR-18-039, will advance outcome measurement for sleep problems in
children (age 3-12 years) with Autism Spectrum Disorder (ASD). Sleep problems (e.g., sleep disturbances and
sleep-related impairments) in children with ASD range from mild to severe and affect as many as 80% in this
age group (Katz et al, 2018).There is no accepted outcome measure for sleep problems in children with ASD.
The absence of a relevant, reliable and valid outcome measure is a barrier to rigorous testing of behavioral or
pharmacological treatments targeting sleep in this population. Using a mixed method design, this multisite,
transdisciplinary project will build a new parent rating for sleep disturbances and related impairments in
children with ASD. The study is guided by methods described in Patient Reported Outcome Measures
(www.Fda.Gov/Cder/Guidance, 2009). This monograph compels investigators to include the patient population
in measure development. Given the age range of this study and likelihood of cognitive or language delays in
children with ASD, we rely on parents as primary informants.
We have an outstanding team of investigators and consultants with expertise in measure development and
sleep problems in ASD. In Year 1, up to six focus groups with parents will explore the onset and behavioral
manifestations of sleep problems in children with ASD. The focus group material will be reviewed and coded to
generate a bank of items (Bearss et al. 2016). These items will be reviewed for clarity and reading level by
parents and an expert panel. In Year 2, the bank of items (version 1 of ASD-Sleep Questionnaire; ASDSQ) will
be placed on a secure website to collect parent-reported data on sleep disturbances and related impairments
in 1200 children with ASD. Items will be scored 0-3 (none, mild, moderate or severe). Factor analysis and item
response theory will be applied to establish the factor structure and prune the item pool toward the final version
(Scahill et al. in press). In Year 3 and early Year 4, an in-person clinical assessment of 135 children with ASD
(age 3-12 years) will be conducted to collect reliability and validity data on the final ASDSQ version. A
subsample of children will be invited to return for test-retest on ASDSQ, 2 weeks and 4 weeks later. In Year 4,
data from the clinical assessment will be used to evaluate convergent validity, divergent validity and test-retest
reliability of the ASDSQ. Also in Year 3 and early Year 4, we will collect five consecutive nights of actigraphy
data in a total of 75 children with ASD (age 3 to 12) to evaluate sleep efficiency (percentage of time sleeping
divided by total time in bed with lights off). Actigraphy-measured sleep efficiency (ASE) will be used to conduct
exploratory analyses comparing ASDSQ scores in children with impaired ASE values (poor sleepers) to those
with acceptable ASE values (good sleepers) (Goldman et al. 2009; Moore et al. 2017). Receiver operating
characteristic curves will be used to explore the sensitivity and specificity of SDSQ on ASE classifications.
项目摘要/摘要。
该应用程序是根据 PAR-18-039 编写的,将推进睡眠问题的结果测量
患有自闭症谱系障碍 (ASD) 的儿童(3-12 岁)。睡眠问题(例如睡眠障碍和
患有自闭症谱系障碍(ASD)儿童的睡眠相关障碍)范围从轻度到重度,影响多达 80%
年龄组(Katz 等人,2018)。对于自闭症谱系障碍儿童的睡眠问题,目前尚无公认的结果衡量标准。
缺乏相关、可靠和有效的结果测量是对行为或行为进行严格测试的障碍。
针对该人群睡眠的药物治疗。使用混合方法设计,这个多站点,
跨学科项目将为睡眠障碍和相关障碍建立新的家长评级
患有自闭症谱系障碍的儿童。该研究以患者报告结果测量中描述的方法为指导
(www.Fda.Gov/Cder/Guidance,2009 年)。该专着迫使研究人员将患者群体纳入其中
在措施发展中。考虑到本研究的年龄范围以及认知或语言延迟的可能性
对于患有自闭症谱系障碍 (ASD) 的儿童,我们依靠父母作为主要信息提供者。
我们拥有一支由研究人员和顾问组成的优秀团队,他们在措施开发和
ASD 的睡眠问题。在第一年,最多六个与家长一起的焦点小组将探讨该病的发病和行为
ASD 儿童睡眠问题的表现。焦点小组材料将被审查并编码为
生成一个项目银行(Bearss et al. 2016)。这些项目的清晰度和阅读水平将由
家长和专家小组。在第 2 年,项目库(ASD 睡眠问卷第 1 版;ASDSQ)将
放置在安全网站上,以收集家长报告的有关睡眠障碍和相关障碍的数据
1200 名患有自闭症谱系障碍 (ASD) 的儿童。项目评分为 0-3(无、轻度、中度或严重)。因素分析及项目
将应用响应理论来建立因子结构并针对最终版本修剪项目池
(Scahill 等人,待出版)。在第 3 年和第 4 年初,对 135 名自闭症谱系障碍 (ASD) 儿童进行了现场临床评估
(3-12 岁)将收集最终 ASDSQ 版本的可靠性和有效性数据。一个
儿童子样本将被邀请在 2 周和 4 周后返回进行 ASDSQ 重测。第四年,
临床评估的数据将用于评估收敛效度、发散效度和重测
ASDSQ 的可靠性。同样在第三年和第四年初期,我们将连续五个晚上收集体动记录
总共 75 名自闭症谱系障碍 (ASD) 儿童(3 至 12 岁)的数据用于评估睡眠效率(睡眠时间百分比)
除以关灯在床上的总时间)。体动记录仪测量的睡眠效率(ASE)将用于进行
探索性分析,比较 ASE 值受损(睡眠不佳者)儿童的 ASDSQ 分数与那些儿童的 ASDSQ 分数
具有可接受的 ASE 值(良好睡眠)(Goldman 等人,2009 年;Moore 等人,2017 年)。接收器操作
特征曲线将用于探讨 SDSQ 对 ASE 分类的敏感性和特异性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael C Edwards其他文献
Michael C Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael C Edwards', 18)}}的其他基金
Measuring Sleep Problems in Children with Autism Spectrum Disorder
测量自闭症谱系障碍儿童的睡眠问题
- 批准号:
10018519 - 财政年份:2019
- 资助金额:
$ 66.79万 - 项目类别:
Measuring Sleep Problems in Children with Autism Spectrum Disorder
测量自闭症谱系障碍儿童的睡眠问题
- 批准号:
10198969 - 财政年份:2019
- 资助金额:
$ 66.79万 - 项目类别:
Measuring Sleep Problems in Children with Autism Spectrum Disorder
测量自闭症谱系障碍儿童的睡眠问题
- 批准号:
10450794 - 财政年份:2019
- 资助金额:
$ 66.79万 - 项目类别:
相似国自然基金
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
年龄结构和空间分布对艾滋病的影响:建模、分析与控制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 66.79万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 66.79万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 66.79万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 66.79万 - 项目类别:
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
- 批准号:
10840238 - 财政年份:2023
- 资助金额:
$ 66.79万 - 项目类别: